13 July 2026
Telehealth GLP-1 prescribing practices may expose patients to unsafe care, weak medical checks and compounded weight-loss drugs.
11 March 2026
Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.
6 January 2026
NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity
8 November 2024
ObesityWeek 2024 attracted unprecedented attention from Wall Street, highlighting obesity treatment's booming pharmaceutical industry.
30 October 2024
Aspen Pharmacare has secured a licensing agreement to enter the GLP-1 agonist market, positioning it for growth in diabetes and obesity treatment solutions.